MiMedx Group, Inc (MDXG)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$4.66−$0.0500 (−1.06%) on the dayAs of the close; data may be delayed.
MDXG price, last 12 months
Key stats
- Previous close
- $4.71
- Open
- $4.71
- Day range
- $4.40 – $4.71
- 52-week range
- $3.03 – $7.97
- Volume
- 1.3M
- Avg volume (20 days)
- 1.2M
- Market cap
- $681.5M
Performance
1W−2.3%
1M+5.4%
3M+18.6%
6M+18.3%
YTD−31.2%
1Y−34.3%
vs S&P 500, 1Y−51.1 pts
Technicals and fundamentals
About MiMedx Group, Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $681.5M